ProShares UltraShort NASDAQ Biotechnology
10 hedge funds and large institutions have $6.05M invested in ProShares UltraShort NASDAQ Biotechnology in 2018 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 2 closing their positions.
Holders
10
Holders Change
-1
Holders Change %
-9.09%
% of All Funds
0.23%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
1
Increased
5
Reduced
3
Closed
2
Calls
$247K
Puts
–
Net Calls
+$247K
Net Calls Change
-$1.15M